TRCT
ARDT

Tower Research Capital (TRC)’s Ardent Health ARDT Stock Holding History

Tower Research Capital (TRC)’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2K Sell
1,895
-2,886
-60% -$25.9K ﹤0.01% 3624
2025
Q4 		$42.2K Buy
4,781
+1,485
+45% +$17.2K ﹤0.01% 2556
2025
Q3 		$43.7K Buy
3,296
+789
+31% +$9.87K ﹤0.01% 2637
2025
Q2 		$34.2K Buy
2,507
+1,462
+140% +$19.7K ﹤0.01% 3304
2025
Q1 		$14.4K Buy
1,045
+593
+131% +$8.65K ﹤0.01% 3299
2024
Q4 		$7.72K Sell
452
-2,947
-87% -$51.1K ﹤0.01% 4053
2024
Q3 		$62.5K Buy
+3,399
New +$60.1K ﹤0.01% 2592

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.18B AUM 19.62% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $80M AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Tower Research Capital (TRC)'s ARDT Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Ardent Health (ARDT) stake by 60% in Q1 2026, selling an estimated $25.9K and leaving 1,895 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3624.

Tower Research Capital (TRC) first reported a position in ARDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $62.5K in Q3 2024. 136 funds tracked by Wall St. Rank hold ARDT as of Q1 2026.

  • Tower Research Capital (TRC) held 1,895 shares of Ardent Health worth $16.2K as of Q1 2026.
  • Tower Research Capital (TRC) sold 2,886 Ardent Health shares in Q1 2026, an estimated $25.9K.
  • Ardent Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3624 holding.
  • Tower Research Capital (TRC) first reported a position in Ardent Health in Q3 2024 and has held it in 7 quarters since.
  • Tower Research Capital (TRC)'s Ardent Health position peaked at $62.5K in Q3 2024.
  • 136 funds tracked by Wall St. Rank held Ardent Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.